Logo

American Heart Association

  37
  2


Final ID: Mo062

Cpne5 is Necessary for Normal Sinoatrial Node Function

Abstract Body:
Background
Cpne5 (Copine 5) is a Ca2+-dependent phospholipid binding protein implicated in membrane trafficking but has no known role within the heart to date. In single-cell RNA-sequencing (scRNA-seq) of the developing mouse heart, we found Cpne5 gene expression to be highly enriched throughout the cardiac conduction system (CCS). Further, variants in CPNE5 were identified in 6 independent GWAS related to heart rate variability in humans. We therefore hypothesize that Cpne5 is necessary for normal CCS function.

Objective
Determine whether Cpne5 is necessary for the normal development and/or function of the CCS.

Methods
To assess the necessity of Cpne5, homozygous systemic knockout (KO) mice were generated using CRISPR/Cas9. Cpne5KO and littermate wild-type (WT) control mice were characterized using surface electrocardiogram (ECG), continuous telemetry and echocardiogram. Protein expression of Cpne5 and CCS-related ion channels were assessed by immunofluorescence of tissue sections, isolated adult murine SAN cells and whole mount immunostaining with 3D volumetric imaging (iDISCO+). Further, CRISPR-mediated deletion of CPNE5 was performed in human induced pluripotent stem cells (hiPSC). Differentiated SAN-like cells were phenotyped via calcium transient (CaT) dynamics and microelectrode array.

Results
Successful deletion of Cpne5 in CRISPR-generated KO mice was confirmed by PCR immunofluorescence. Homozygous Cpne5KO mice were viable, showed normal growth and allele frequencies segregated in a normal Mendelian fashion. No gross anatomic defects of the CCS were observed in Cpne5KO mice and transthoracic echocardiogram studies showed slight reduction in left ventricular fractional shortening but otherwise a structurally normal heart. Notably, while surface electrocardiogram (ECG) demonstrated normal intervals (PR, QRS, QTc), Cpne5KO mice exhibited pronounced sinus arrhythmia, sinus pauses, and increased heart rate variability compared to WT controls on long term telemetry. Additionally, CPNE5KO hiPSC-derived SAN-like cells exhibited irregular CaT as well as significant beat period variability compared to isogenic WT controls.

Conclusion
Systemic loss-of-function of Cpne5 in mice resulted in sinus node dysfunction, consistent with an hiPSC-derived SAN model and human GWAS data, implicating a novel, cell-intrinsic role for Cpne5 in CCS function and/or development. Additional phenotyping and molecular studies are ongoing to further elucidate the underlying mechanism.
  • Dang, Katherine  ( Stanford School of Medicine , Stanford , California , United States )
  • Goodyer, William  ( Stanford University , Palo Alto , California , United States )
  • Ren, Lu  ( Stanford University , Palo Alto , California , United States )
  • Atzert, Felix  ( Stanford , Menlo Park , California , United States )
  • Thai, Phung  ( UC Davis , Davis , California , United States )
  • Mantri, Sruthi  ( Stanford School of Medicine , Stanford , California , United States )
  • Duan, Lauren  ( Stanford University , Palo Alto , California , United States )
  • Beyersdorf, Benjamin  ( University Hospital Zurich , Zurich , Switzerland )
  • Chiamvimonvat, Nipavan  ( University of California, Davis , Davis , California , United States )
  • Wu, Sean  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Author Disclosures:
    Katherine Dang: DO NOT have relevant financial relationships | William Goodyer: DO NOT have relevant financial relationships | Lu Ren: DO NOT have relevant financial relationships | Felix Atzert: No Answer | Phung Thai: DO NOT have relevant financial relationships | Sruthi Mantri: No Answer | Lauren Duan: DO NOT have relevant financial relationships | Benjamin Beyersdorf: DO NOT have relevant financial relationships | Nipavan Chiamvimonvat: DO NOT have relevant financial relationships | Sean Wu: DO have relevant financial relationships ; Individual Stocks/Stock Options:Silver Creek Pharmaceutical, Inc.:Active (exists now) ; Consultant:Bosch USA:Past (completed) ; Advisor:Silver Creek Pharmaceutical, Inc.:Past (completed) ; Research Funding (PI or named investigator):Silver Creek Pharmaceutical, Inc.:Past (completed)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

Poster Session and Reception I

Monday, 07/22/2024 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
A Novel Anti-Thrombotic and Anti-AF Drug without an Adverse Bleeding Problem

Ricchiuti Nikola, Niebrzydowski Maxwell, Richardson Abigail, Yan Jiajie, Ai Xun

Atrial Fibrillation Outcomes in Carcinoid Tumor: A National Inpatient Sample (NIS) Study (2018-2020)

Gaddam Mrunanjali, Nanavaty Dhairya, Sanka Sujana, Thanneeru Priya, Iqbal Rabia, Jayakumar Jayalekshmi, Ginjupalli Manasa, Baddula Sowmya, Reddy Sarath

More abstracts from these authors:
Functional Roles of Small Conductance Ca²⁺-activated K⁺ Channels in Health and Disease

Chiamvimonvat Nipavan

Multiscale Drug Screening for Cardiac Fibrosis Identifies MD2 as a Therapeutic Target

Zhang Hao, Mukherjee Souhrid, Leitz Jeremy, Wen Wilson, Shin Hye, Liu Wenqiang, Chiamvimonvat Nipavan, Wu Joseph, Thai Phung, Shivnaraine Rabindra, Ren Lu, Wu Xuekun, Siepe Dirk, Liu Yu, Tu Chengyi, Caudal Arianne

You have to be authorized to contact abstract author. Please, Login
Not Available